Aoxing Pharmaceutical Company, Inc. (AOXG)

AOXG Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019	2016	2015	2014	2013	2012	2011 - 2005
Net Income	0	0	0	0	0	2.06	5.49	-8.22	-16.8	-15.82	Upgrade
Depreciation & Amortization	0	0	0	0	0	1.03	0.67	0.99	1.11	1.08	Upgrade
Share-Based Compensation	0	0	0	0	0	0.79	-0.12	0.02	0	0	Upgrade
Other Operating Activities	-	-	-	-	-	-4.41	-3.02	-0.52	7.37	13.41	Upgrade
Operating Cash Flow	0	0	0	0	0	-0.53	3.03	-7.73	-8.32	-1.33	Upgrade
Capital Expenditures	0	0	0	0	0	-0.12	-2.71	-0.27	-0.44	-0.75	Upgrade
Investing Cash Flow	0	0	0	0	0	-0.12	-2.71	-0.27	-0.44	-0.75	Upgrade
Common Stock Issued	0	0	0	0	0	2.74	2.42	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-	0.21	0.25	6.31	8.99	2.82	Upgrade
Financing Cash Flow	0	0	0	0	0	2.95	2.67	6.31	8.99	2.82	Upgrade
Net Cash Flow	0	0	0	0	0	1.54	3.04	-1.68	0.33	0.91	Upgrade
Free Cash Flow	0	0	0	0	0	-0.65	0.32	-8	-8.76	-2.08	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-2.02%	1.26%	-62.79%	-80.86%	-25.55%	Upgrade
Free Cash Flow Per Share	-	-	-	-	-	-0.01	0.01	-0.16	-0.18	-0.04	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.